Dear Colleague,

The creation of a new drug is a very long and expensive process. Faster and more
efficient drug discovery is still the key to the pharmaceutical industry’s survival.

Data management and knowledge discovery have become the core practices of every R&D department to aid achievement of ambitious goals regarding drug development.
After having implemented LIMS and ELN as necessary databases, pharmaceutical companies are looking now for potential solutions regarding knowledge discovery.

For this reason the next step is already determined: Bringing up-to-the-minute knowledge to reality by integrating intelligent search and analyzing tools with the latest findings and experiences in the lab. Text-mining and data-mining not only help to unearth information, but also enable prognoses of new drug discovery. Pooling this worldwide knowledge allows specialists all around the globe to get in touch and share their experiences.

That is why you can’t afford to miss IQPC’s international conference:

High-level speakers from companies such as Bayer HealthCare, Ariana Pharmaceuticals, Allergan, Æterna Zentaris, Rhodia Group, Abbott and many more will report about first-hand experiences and latest developments.